Interappointment pain experience with a new endodontic medicament: a randomised controlled trial

Phase 3

• Conditions: Apical periodontitis; Pulpal inflammation; Inflammatory and Immune System - Other inflammatory or immune system disorders; Oral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon

• Registration Number: ACTRN12612000630819
• Lead Sponsor: The University of Melbourne

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-06-12
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 24

Inclusion Criteria

Restorable teeth suitable for root canal treatment over multiple visits.
A coherent understanding of English so that explanations and instructions can be followed.

Exclusion Criteria

Patients who cannot communicate in English
Visually impaired patients who cannot complete the pain recording sheet
Allergy to any of the medicament contents, including ibuprofen and other drugs in the same class (non steroidal anti-inflammatory drugs)
Asthmatic patients
Patients taking warfarin
Pregnant women
An eligible tooth where at least one other tooth in the same quadrant requires root canal treatment or removal

Study & Design

• Study Type: Interventional
• Study Design: Not specified